Add to ORKGCirculating microRNAs (miRNAs) are extensively studied in cancer as biomarkers but little is known about the influence of anti-cancer drugs on their expression. In this presentation, we describe the modifications of circulating miRNAs profile under neoadjuvant chemotherapy (NAC) for breast cancer.Circulating microRNAs as diagnostic, prognostic and predictive markers in breast cancer patient
BackgroundMicroRNAs (miRNAs) have been recently detected in the circulation of cancer patients, wher...
Purpose: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; ho...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...
Breast cancer is the leading cause of death by cancer among women and there is an urgent need to imp...
Circulating microRNAs (miRNAs) have been extensively studied in cancer as biomarkers but little is ...
Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In recent years...
Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden pr...
Background: Neoadjuvant chemotherapy (NACT) is an increasingly used approach for treatment of breast...
Background: Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of ...
BACKGROUND: Chemotherapy is an important component in the treatment paradigm for breast cancers. How...
Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of patients who...
Background Conventionally, breast cancer (BC) prognosis and prediction of response to therapy are ba...
<div><p>Introduction</p><p>MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in ca...
INTRODUCTION:MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer progressi...
Background: The aim of this study is to identify miRNAs able to predict the outcomes in breast cance...
BackgroundMicroRNAs (miRNAs) have been recently detected in the circulation of cancer patients, wher...
Purpose: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; ho...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...
Breast cancer is the leading cause of death by cancer among women and there is an urgent need to imp...
Circulating microRNAs (miRNAs) have been extensively studied in cancer as biomarkers but little is ...
Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In recent years...
Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden pr...
Background: Neoadjuvant chemotherapy (NACT) is an increasingly used approach for treatment of breast...
Background: Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of ...
BACKGROUND: Chemotherapy is an important component in the treatment paradigm for breast cancers. How...
Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of patients who...
Background Conventionally, breast cancer (BC) prognosis and prediction of response to therapy are ba...
<div><p>Introduction</p><p>MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in ca...
INTRODUCTION:MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer progressi...
Background: The aim of this study is to identify miRNAs able to predict the outcomes in breast cance...
BackgroundMicroRNAs (miRNAs) have been recently detected in the circulation of cancer patients, wher...
Purpose: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; ho...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...